Granules India posts Q4 FY25 PAT at Rs. 152 Cr
The company reported sustained increase in formulations' share despite slowdown in productivity of Gagillapur facility
The company reported sustained increase in formulations' share despite slowdown in productivity of Gagillapur facility
The company has posted net profit of Rs. 1,414.44 crores for the Financial Year ended March 31, 2025
Standalone profit from operations for the quarter were Rs. 162 crores
The company has posted net profit of Rs. 1,767.63 crores for the Financial Year ended March 31, 2025
We are witnessing a steady and sustainable growth in the country as the Q2 revenue from operations increased by 31%
Granules India has reported total income of Rs. 1181.92 crores during the period ended June 30, 2024
Profit Before Tax is Rs. 220 crore, registering a commendable 64% growth
The company has posted net profit of Rs. 405.31 crores for the Financial Year ended March 31, 2024
Sanofi India has reported total income of Rs. 738.9 crores during the period ended March 31, 2024
Novartis India has reported total income of Rs. 91.59 crores during the period ended March 31, 2024
Subscribe To Our Newsletter & Stay Updated